Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-426.72M
↓ 100% below average
Average (5y)
$-212.86M
Historical baseline
Range
High:$-58.34M
Low:$-426.72M
CAGR
+48.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-426.72M | -38.7% |
| 2023 | $-307.63M | -35.1% |
| 2022 | $-227.66M | -30.0% |
| 2021 | $-175.12M | -114.3% |
| 2020 | $-81.70M | -40.1% |
| 2019 | $-58.34M | - |